Shareholders
At Viridien, we are committed to delivering sustainable value to our stakeholders. We remain focused on ensuring that our group generates positive cash flow throughout industry cycles.
Results and Publications
To keep our shareholders and other interested parties informed, Viridien prepares a number of documents and conference presentations throughout the year.
Corporate Governance
This page provides access to all regulated information (in accordance with the AMF General Regulation, article 221-1) published by Viridien.
Regulated Information
This page provides access to all regulated information (in accordance with the AMF General Regulation, article 221-1) published by Viridien.
Events Calendar
Learn more about upcoming financial events.
Investors Contact
Investor Information Request
Request additional investor information about Viridien, or access our digital investor package.
Financing
View information on outstanding bonds, credit ratings and rating outlooks for Viridien.
Corporate Presentation
Get an overview of our strategic, business and financial activities in a single presentation.
Resources & News
View all
CGG Announces its Q2 2023 Results
Paris, France | Jul 27, 2023CGG , a global technology and high-performance computing (HPC) leader, announced today its second quarter 2023 non-audited results.
Launch of Viridien (ex-CGG) reverse share split
Viridien (the “Company”) announces the implementation of the reverse share split on the basis of 1 new share of €1.00 nominal value for 100 old shares of €0.01 nominal value (the “Reverse Share Split”). ...
Imaging uplift overcomes mapping challenges of Lower Cretaceous Agat Play
The northern North Sea is a very active oil and gas exploration region, where several commercial discoveries have been made over recent years. The Lower Cretaceous sands within the Agat Formation is a reservoir play that has been targeted for decades ...
HPC Perspectives: Episode 6
Embark on a journey through the cutting-edge world of drug discovery and artificial intelligence (AI) with Gemma and Natalia . Discover how data and AI are revolutionizing the pharmaceutical landscape, uncovering new insights, and propelling medical ...